This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Cardiovascular Diseases
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The objective of this study is to define the repeatability and reproducibility of quantifying flow-mediated dilation (FMD) of the brachial artery (BA) using the AngioDefender (AD) methodology. Repeatability will be assessed by repeat AD testing of the same subject 1 hour apart, using the same AD device and operator. Reproducibility will be assessed by comparing FMD scores obtained for the same subject, but using different AD devices and operators.

Provided treatments

  • Device: AngioDefender

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02641197. The sponsor of the trial is Everist Genomics, Inc and it is looking for 20 volunteers for the current phase.
Official trial title:
Vascular Reactivity Assessment by AngioDefender -- A Repeatability and Reproducibility Study